For decades, the idea that creativity comes from the right side of the brain has dominated popular culture. People have been ...

In December 2024, Praxis received Rare Pediatric Disease Designation (RPDD) from the U.S. Food and Drug Administration (FDA) for relutrigine for Dravet Syndrome. This is the third RPDD for relutrigine ...

Early results were shared during the Praxis scientific exhibit at the December 2024 American Epilepsy Society Annual Meeting, demonstrating significant disease burden compounded by persistent, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...